Mayflower Financial Advisors LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 2.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,691 shares of the healthcare conglomerate’s stock after purchasing an additional 85 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,744,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Chesapeake Wealth Management raised its holdings in UnitedHealth Group by 7.0% in the fourth quarter. Chesapeake Wealth Management now owns 4,992 shares of the healthcare conglomerate’s stock worth $2,647,000 after purchasing an additional 326 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $87,114,000. Beaumont Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $2,299,000. Ruedi Wealth Management Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $64,000. Finally, Aries Wealth Management increased its holdings in shares of UnitedHealth Group by 1.3% during the first quarter. Aries Wealth Management now owns 3,533 shares of the healthcare conglomerate’s stock valued at $1,670,000 after acquiring an additional 47 shares in the last quarter. 92.61% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Down 0.4 %
Shares of NYSE:UNH opened at $477.00 on Friday. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The firm has a market capitalization of $444.10 billion, a price-to-earnings ratio of 21.81, a price-to-earnings-growth ratio of 1.34 and a beta of 0.68. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.81 and a quick ratio of 0.81. The business’s 50 day moving average price is $485.19 and its 200-day moving average price is $492.64.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 27th. Investors of record on Monday, June 19th will be paid a $1.88 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a yield of 1.58%. The ex-dividend date is Thursday, June 15th. UnitedHealth Group’s dividend payout ratio is currently 34.39%.
Analyst Ratings Changes
Several research firms have recently issued reports on UNH. TD Cowen cut their price objective on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating on the stock in a report on Monday, April 17th. Truist Financial dropped their target price on UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. Royal Bank of Canada reiterated an “outperform” rating and issued a $592.00 target price on shares of UnitedHealth Group in a research report on Monday, April 17th. Stephens reiterated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Tuesday, February 28th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Monday, April 17th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $592.68.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the completion of the sale, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total value of $3,002,938.40. Following the completion of the sale, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the completion of the sale, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at $5,019,764.22. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,852 shares of company stock valued at $4,313,962. 0.35% of the stock is owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Get a free research report on UnitedHealth Group from StockNews.com
- CarMax Stock Flying On Earnings Beat, Return Of The Highs?
- Commercial Metals Company Shakes Off The Rust: Confirms Uptrend
- Smith & Wesson, A Timeless Value Play At Decade Lows
- Wayfair: From Steep Decline to Recent Surge
- Five stocks we like better than UnitedHealth Group
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
